Swain SM - Search Results

1

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.

Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, Wang H, Toney NJ, Jochems C, Schlom J, Zeck J, Gallagher C, Nanda R, Graham D, Stringer-Reasor EM, Denduluri N, Collins J, Chitalia A, Tiwari S, Nunes R, Kaltman R, Khoury K, Gatti-Mays M, Tarantino P, Tolaney SM, Swain SM, Pohlmann P, Parsons HA, Isaacs C. Lynce F, et al. Among authors: swain sm. Nat Commun. 2024 Mar 27;15(1):2691. doi: 10.1038/s41467-024-46961-x. Nat Commun. 2024. PMID: 38538574 Free PMC article. Clinical Trial.

2

Therapy of patients with metastatic breast cancer with 5-fluorouracil, leucovorin and carboplatin.

Pai LH, Swain SM, Venzon DJ, Reed E, Poirier MC, Gupta-Burt S, Denicoff AM, Allegra CJ. Pai LH, et al. Among authors: swain sm. Anticancer Drugs. 1992 Oct;3(5):463-9. doi: 10.1097/00001813-199210000-00003. Anticancer Drugs. 1992. PMID: 1450439 Clinical Trial.

3

Adjuvant therapy in early breast cancer.

Chittoor SR, Swain SM. Chittoor SR, et al. Among authors: swain sm. Am Fam Physician. 1991 Aug;44(2):453-62. Am Fam Physician. 1991. PMID: 1858602 Review.

4

Hormone replacement therapy in women with a history of breast carcinoma.

Isaacs CJ, Swain SM. Isaacs CJ, et al. Among authors: swain sm. Hematol Oncol Clin North Am. 1994 Feb;8(1):179-95. Hematol Oncol Clin North Am. 1994. PMID: 8150779 Review.

5

Update on adjuvant chemotherapy for early breast cancer.

McCarthy NJ, Swain SM. McCarthy NJ, et al. Among authors: swain sm. Oncology (Williston Park). 2000 Sep;14(9):1267-80; discussion 1280-4, 1287-8. Oncology (Williston Park). 2000. PMID: 11033824 Free article. Review.

6

Adjuvant chemotherapy for breast cancer: an update.

Tan AR, Swain SM. Tan AR, et al. Among authors: swain sm. Semin Oncol. 2001 Aug;28(4):359-76. doi: 10.1016/s0093-7754(01)90130-7. Semin Oncol. 2001. PMID: 11498830 Review.

7

Ongoing adjuvant trials with trastuzumab in breast cancer.

Tan AR, Swain SM. Tan AR, et al. Among authors: swain sm. Semin Oncol. 2003 Oct;30(5 Suppl 16):54-64. doi: 10.1053/j.seminoncol.2003.08.008. Semin Oncol. 2003. PMID: 14613027 Review.

8

A pilot study to evaluate the vascular endothelial growth factor receptor tyrosine kinase inhibitor AZD2171 and chemotherapy in locally advanced and inflammatory breast cancer.

Denduluri N, Tan AR, Walshe J, Berman A, Yang SX, Chow CK, Swain SM. Denduluri N, et al. Among authors: swain sm. Clin Breast Cancer. 2005 Dec;6(5):460-3. doi: 10.3816/CBC.2005.n.052. Clin Breast Cancer. 2005. PMID: 16381631 No abstract available.

9

A phase II trial with trastuzumab and pertuzumab in patients with HER2-overexpressed locally advanced and metastatic breast cancer.

Walshe JM, Denduluri N, Berman AW, Rosing DR, Swain SM. Walshe JM, et al. Among authors: swain sm. Clin Breast Cancer. 2006 Feb;6(6):535-9. doi: 10.3816/CBC.2006.n.009. Clin Breast Cancer. 2006. PMID: 16595039 Clinical Trial. No abstract available.

10

Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer.

Denduluri N, Lee JJ, Walshe J, Berman AW, Vatas U, Chow CK, Steinberg SM, Cox MC, Low JA, Swain SM. Denduluri N, et al. Among authors: swain sm. Invest New Drugs. 2007 Feb;25(1):63-7. doi: 10.1007/s10637-006-9006-7. Epub 2006 Aug 25. Invest New Drugs. 2007. PMID: 16933153 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page